NeoGlyco Therapeutics is a cutting-edge start-up, leading the development of new generation novel anti-cancer antibodies using our advanced custom phage library. Our Dual Specificity Antibodies target a specific part of a cancer cell protein that includes two key features. This innovation could lead many potential markers with significant clinical benefits to become successful antibody targets, and reducing or even eliminating harmful side effects.
Company Details
- Founded
- -
- Address
- Koll Center Pkwy, Pleasanton,california,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://neoglyco.com/
- Keywords
- FNL Institute.
- HQ
- Pleasanton, California
Neoglyco Therapeutics Questions
Neoglyco Therapeutics's website is https://neoglyco.com/
Neoglyco Therapeutics's LinkedIn profile is https://www.linkedin.com/company/neoglyco-therapeutics
Neoglyco Therapeutics's industry is
Biotechnology Research
Neoglyco Therapeutics's top competitors are
Stealth Ai Startup,
Mo Batteries Singapore Pte Ltd,
Fnl Institute,
Turtletree,
Norton Hospitality Group,
Unreasonable,
Tw1 Healthcare Consulting,
Icare Singapore,
Shona Prince Technologies,
Eurofins Nutrition Analysis Center (Enac).
Neoglyco Therapeutics's categories are Biotechnology Research
Neoglyco Therapeutics's founding year is 2024
